Related Experiment Video
Updated: May 15, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Ethical challenges in advanced heart failure
Vinay Kini1, James N Kirkpatrick
1Cardiovascular Medicine Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Insights
Caring for advanced heart failure (AHF) patients presents ethical challenges due to new therapies. Addressing these requires improved prognostication, informed consent, palliative care, and multidisciplinary approaches for optimal patient outcomes.
Area of Science:
- Cardiology
- Medical Ethics
- Palliative Care
Background:
- Advanced heart failure (AHF) is a growing concern with expanding treatment options.
- Therapeutic and diagnostic interventions for AHF are increasing, leading to complex ethical dilemmas.
Purpose of the Study:
- To discuss the ethical challenges in advanced heart failure care.
- To propose an approach for managing patients with advanced heart failure.
Main Methods:
- Review of recent guidelines and clinical trials on AHF therapies.
- Analysis of ethical considerations related to advanced interventions.
Main Results:
- Costly, invasive therapies like ventricular assist devices and cardiac resynchronization therapy prolong life but pose end-of-life challenges.
- Prognostication, informed consent, and palliative care are crucial for managing decision-making.
- Societal factors like cost-effectiveness and distributive justice impact device dissemination.
Conclusions:
- Optimal AHF care necessitates further research and enhanced end-of-life education.
- Emphasis on advance directives and comprehensive informed consent is vital.
- A true multidisciplinary approach is essential for effective patient management.
Purpose Of Review:
Advanced heart failure (AHF) is an increasingly important field. Both the population of AHF patients and the therapeutic and diagnostic interventions available are expanding, creating a host of difficult ethical challenges. This article discusses these important issues and proposes an approach to caring for AHF patients.
Recent Findings:
Recent guidelines and clinical trials describe the benefits of costly and invasive therapies for AHF, such as ventricular assist devices and cardiac resynchronization therapy which prolong life and improve symptoms but may create burdens and conflict over deactivation at the end of life. Prognostication, informed consent, and early involvement of palliative care are central to addressing the decision-making challenges raised by these devices. Societal concerns such as cost-effectiveness and distributive justice will play an increasingly important role in the dissemination of these devices.
Summary:
More research, increased end-of-life education, emphasis on advance directives, a more comprehensive informed consent process, and a true multidisciplinary approach are needed to provide optimal care for patients with AHF.
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Ethical Issues
Ethical Concerns in Healthcare:
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure